Daiichi-Sankyo is a global pharmaceutical company with corporate origins in Japan. Daiichi-Sankyo provides innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
www.Daiichi-Sankyo.com Daiichi-Sankyo Europe supports the Cardio Update Europe 2026 as a Premium Partner.
As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases.
www.Bayer.com Bayer supports the Cardio Update Europe 2026 as a Gold Partner.
Bold thinking. Bolder actions. We are Medtronic.
www.Medtronic.com We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for all.
In everything we do, we are engineering the extraordinary.
Medtronic supports the Cardio Update Europe 2026 as a Silver Partner.
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.
www.Edwards.com Edwards Lifesciences supports the Cardio Update Europe 2026 as a Partner.
